These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19852561

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
    Greenberg MS, Burton GA, Fisher JW.
    Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):264-78. PubMed ID: 9931286
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mechanisms of the dose-dependent kinetics of trichloroethylene: oral bolus dosing of rats.
    Lee KM, Muralidhara S, White CA, Bruckner JV.
    Toxicol Appl Pharmacol; 2000 Apr 01; 164(1):55-64. PubMed ID: 10739744
    [Abstract] [Full Text] [Related]

  • 25. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 01; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
    Liao CM, Shen HH, Chen CL, Hsu LI, Lin TL, Chen SC, Chen CJ.
    J Hazard Mater; 2009 Jun 15; 165(1-3):652-63. PubMed ID: 19062162
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Issues in the pharmacokinetics of trichloroethylene and its metabolites.
    Chiu WA, Okino MS, Lipscomb JC, Evans MV.
    Environ Health Perspect; 2006 Sep 15; 114(9):1450-6. PubMed ID: 16966104
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Metabolism, toxicity, and carcinogenicity of trichloroethylene.
    Bruckner JV, Davis BD, Blancato JN.
    Crit Rev Toxicol; 1989 Sep 15; 20(1):31-50. PubMed ID: 2673291
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.
    Krishnan K, Johanson G.
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005 Sep 15; 23(1):31-53. PubMed ID: 16291521
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO.
    Drug Metab Rev; 1996 Sep 15; 28(1-2):149-79. PubMed ID: 8744594
    [Abstract] [Full Text] [Related]

  • 39. Initial uptake kinetics in human skin exposed to dilute aqueous trichloroethylene in vitro.
    Bogen KT, Keating GA, Meissner S, Vogel JS.
    J Expo Anal Environ Epidemiol; 1998 Sep 15; 8(2):253-71. PubMed ID: 9577754
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.